KTTA stock

Pasithea Therapeutics Corp (KTTA) financials · $5.6M cap

Pasithea Therapeutics Corp (KTTA) $5.6M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$20.9M-$14.2M
Net Income-$20.4M-$13.9M
EPS (Diluted)$-2.91$-12.69
Cached annual balance sheet
LineFY2025FY2024
Total Assets$60.2M$16.1M
Current Assets$56.5M$7.4M
Cash & Equivalents$55.2M$6.9M
Inventory$0$0
PP&E$0$122.3K
Total Liabilities$5.0M$1.3M
Current Liabilities$5.0M$1.1M
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity$55.2M$14.8M
Retained Earnings-$70.0M-$49.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$15.2M-$13.9M
CapEx$0$0
Investing Cash Flow$11.0K$0
Financing Cash Flow$63.5M$4.5M
Dividends Paid$0$0
Net Change in Cash$48.3M-$9.4M
Free Cash Flow$0$0

FAQ

What is KTTA P/E and revenue?

Pasithea Therapeutics Corp (KTTA) $5.6M cap.

What is KTTA revenue?

Pasithea Therapeutics Corp last cached revenue is $0 (FY2025).

Is KTTA profitable?

Pasithea Therapeutics Corp last cached net income is -$20.4M.

What are KTTA total assets?

Pasithea Therapeutics Corp last cached total assets are $60.2M.

What is KTTA free cash flow?

Pasithea Therapeutics Corp last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.